$CMPX
Compass Therapeutics, Inc. Stock $cmpx

2020 Q1 Form 10-Q Financial Statement

Concept	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$17.79M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$124.8M
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Concept	2020 Q1
OPERATING ACTIVITIES
Net Income	-$6.402M
YoY Change	-40.56%
Depreciation, Depletion And Amortization	$500.0K
YoY Change
Cash From Operating Activities	-$7.761M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	$12.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$12.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities	-7.761M
Cash From Investing Activities	-12.00K
Cash From Financing Activities
Net Change In Cash	-7.773M
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$7.761M
Capital Expenditures	$12.00K
Free Cash Flow	-$7.773M
YoY Change

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5000000	shares